The consortium will establish several initiatives during the 48-month project to accomplish the following goals:
Novel imaging procedures that result in new high-resolution approaches and new super-resolution imaging procedures.
Creation of instruments and procedures that bridge the gap between in vitro and in vivo testing.
The provision of reliable data, enhanced data reporting, and, eventually, the creation of standardised, harmonised test procedures for use in regulatory frameworks.
Creating guidelines for toxicological testing and filling the present gaps in nanotoxicology.
Product and material development efficiency.